Literature DB >> 25091965

Noninvasive stress testing for coronary artery disease.

Todd D Miller1, J Wells Askew2, Nandan S Anavekar2.   

Abstract

Stress testing remains the cornerstone for noninvasive assessment of patients with possible or known coronary artery disease (CAD). The most important application of stress testing is risk stratification. Most patients who present for evaluation of stable CAD are categorized as low risk by stress testing. These low-risk patients have favorable clinical outcomes and generally do not require coronary angiography. Standard exercise treadmill testing is the initial procedure of choice in patients with a normal or near-normal resting electrocardiogram who are capable of adequate exercise. Stress imaging is recommended for patients with prior revascularization, uninterpretable electrocardiograms, or inability to adequately exercise.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dobutamine echocardiography; Exercise echocardiography; Exercise treadmill testing (ETT); Myocardial perfusion imaging (MPI); Positron emission tomography (PET); Single-photon emission computed tomography (SPECT); Stress testing

Mesh:

Year:  2014        PMID: 25091965     DOI: 10.1016/j.ccl.2014.04.008

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  3 in total

Review 1.  Stress echocardiography: what is new and how does it compare with myocardial perfusion imaging and other modalities?

Authors:  Marysia S Tweet; Adelaide M Arruda-Olson; Nandan S Anavekar; Patricia A Pellikka
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

2.  Influence of hemodialysis on regadenoson clearance in an in vitro hemodialysis model.

Authors:  Katherine N Gharibian; Venkatesh L Murthy; Bruce A Mueller
Journal:  J Nucl Cardiol       Date:  2016-09-15       Impact factor: 5.952

3.  Clinical use of submaximal treadmill exercise testing and assessments of cardiac biomarkers NT-proBNP and cTnI in dogs with presymptomatic mitral regurgitation.

Authors:  Leona Wall; Annika Mohr; Florenza Lüder Ripoli; Nayeli Schulze; Camila Duarte Penter; StephanOscar Hungerbuehler; Jan-Peter Bach; Karin Lucas; Ingo Nolte
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.